Flagship Harbor Advisors’s Regenxbio RGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
– Sell
-17
Closed – – 1483
2020
Q3
$0 Hold
17
– – ﹤0.01% 2126
2020
Q2
$0 Hold
17
– – ﹤0.01% 2130
2020
Q1
$1K Hold
17
– – ﹤0.01% 1795
2019
Q4
$1K Hold
17
– – ﹤0.01% 1819
2019
Q3
$0 Hold
17
– – ﹤0.01% 1944
2019
Q2
$0 Hold
17
– – ﹤0.01% 1959
2019
Q1
$0 Hold
17
– – ﹤0.01% 1931
2018
Q4
$0 Hold
17
– – ﹤0.01% 2051
2018
Q3
$1K Hold
17
– – ﹤0.01% 2005
2018
Q2
$1K Buy
+17
New +$812 ﹤0.01% 1962

Other funds holding RGNX

Flagship Harbor Advisors's RGNX Position: Q4 2020 in Review

Flagship Harbor Advisors sold out of Regenxbio (RGNX) in Q4 2020, closing a stake of 17 shares.

Flagship Harbor Advisors first reported a position in RGNX in Q2 2018 and held it in 10 quarters. The position peaked at $1K in Q1 2020. 187 funds tracked by Wall St. Rank hold RGNX as of Q4 2020.

  • Flagship Harbor Advisors reported no remaining Regenxbio position as of Q4 2020 after selling out during the quarter.
  • Flagship Harbor Advisors sold 17 Regenxbio shares in Q4 2020.
  • Flagship Harbor Advisors first reported a position in Regenxbio in Q2 2018 and held it in 10 quarters.
  • Flagship Harbor Advisors's Regenxbio position peaked at $1K in Q1 2020.
  • 187 funds tracked by Wall St. Rank held Regenxbio as of Q4 2020.

Based on Flagship Harbor Advisors's 13F filing for Q4 2020, filed 8 Feb 2021.